A difficult trade off for adults with membranous nephropathyBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f248 (Published 16 January 2013) Cite this as: BMJ 2013;346:f248
Immunosuppression is an established but controversial treatment for patients with idiopathic membranous nephropathy. Supporting evidence is patchy, particularly for the minority of patients with worsening renal function. A new trial reports that the combination of chlorambucil and prednisolone does slow …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial